Sigma-Aldrich Corp.

NAS : SIAL
Pharmaceuticals
St. Louis Missouri
2011 Revenue (US$ Millions)$2,505
2010 Revenue (US$ Millions)$2,271
Revenue Growth (%)10.30%
Net Income (US$ Millions)$457
Common Shares Outstanding (Millions)$121
Earnings Per Share (US$)$3.72
Earnings Per Share Growth (%)19.23%
Price To Earnings Ratio20.06
Total Equity (US$ Millions)$2,199
Profit Growth (%)19.01
Profit Margin (%)18.24%
Return On Equity (%)23.13%
Long Term Debt (US$ Millions)$300
Debt To Equity Ratio (%)0.14%
Market Capitalization (US$ Millions)$7,558
Total Assets (US$ Millions)$3,281
Return on Assets (%)15.16
Current Assets (US$ Millions)$1,793
Inventories (US$ Millions)$668
Current Liabilities (US$ Millions)$538
Cost of Goods Sold (US$ Millions)$1,181
Asset Turnover0.76
Inventory Turnover1.85